The Safety, Preliminary Pharmacodynamics and Pharmacokinetics Study of rExenatide-4 in Chinese T2DM

Trial Profile

The Safety, Preliminary Pharmacodynamics and Pharmacokinetics Study of rExenatide-4 in Chinese T2DM

Completed
Phase of Trial: Phase II

Latest Information Update: 20 Sep 2017

At a glance

  • Drugs Exenatide (Primary) ; Metformin
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms SPPS
  • Sponsors CSPC Pharma
  • Most Recent Events

    • 20 Sep 2017 Results assessing the tolerability, pharmacokinetics, pharmacodynamics and efficacy of oral exenatide-4 compared with metformin in Chinese patients with type 2 diabetes mellitus, were published in the Clinical Drug Investigation.
    • 20 Sep 2017 Status changed from recruiting to completed, according to results published in the Clinical Drug Investigation.
    • 10 Jun 2017 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top